Table of Contents Author Guidelines Submit a Manuscript
International Journal of Vascular Medicine
Volume 2013, Article ID 548764, 7 pages
http://dx.doi.org/10.1155/2013/548764
Clinical Study

Influence of Peripheral Artery Disease and Statin Therapy on Apolipoprotein Profiles

1Reynolds Oklahoma Center on Aging, Donald W. Reynolds Department of Geriatric Medicine, University of Oklahoma Health Sciences Center (OUHSC), Oklahoma City, OK 73117, USA
2Veterans Affairs Medical Center, Oklahoma City, OK 73104, USA
3University of Oklahoma Health Sciences Center, O’Donoghue Research Building, 1122 NE 13th Street, Suite 1200, Oklahoma City, OK 73117, USA
4Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA
5Department of Biostatistics and Epidemiology, OUHSC, Oklahoma City, OK 73117, USA
6Cardiovascular Section, Department of Medicine, OUHSC, Oklahoma City, OK 73117, USA

Received 23 June 2013; Accepted 12 August 2013

Academic Editor: Mark Morasch

Copyright © 2013 Andrew W. Gardner et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. L. Roger, A. S. Go, D. M. Lloyd-Jones et al., “Executive summary: heart disease and stroke statistics—2012 update: a report from the American heart association,” Circulation, vol. 125, no. 1, pp. 188–197, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. A. T. Hirsch, Z. J. Haskal, N. R. Hertzer et al., “ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation,” Circulation, vol. 113, no. 11, pp. e463–e654, 2006. View at Google Scholar · View at Scopus
  3. L. Norgren, W. R. Hiatt, J. A. Dormandy, M. R. Nehler, K. A. Harris, and F. G. R. Fowkes, “Inter-society consensus for the management of peripheral arterial disease (TASC II),” Journal of Vascular Surgery, vol. 45, no. 1, pp. S5–S67, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. E. P. Brass and W. R. Hiatt, “Review of mortality and cardiovascular event rates in patients enrolled in clinical trials for claudication therapies,” Vascular Medicine, vol. 11, no. 3, pp. 141–145, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. M. H. Criqui, R. D. Langer, A. Fronek et al., “Mortality over a period of 10 years in patients with peripheral arterial disease,” The New England Journal of Medicine, vol. 326, no. 6, pp. 381–386, 1992. View at Google Scholar · View at Scopus
  6. A. T. Hirsch, L. Hartman, R. J. Town, and B. A. Virnig, “National health care costs of peripheral arterial disease in the Medicare population,” Vascular Medicine, vol. 13, no. 3, pp. 209–215, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. A. W. Gardner, J. S. Skinner, B. W. Cantwell, and L. K. Smith, “Progressive vs single-stage treadmill tests for evaluation of claudication,” Medicine & Science in Sports & Exercise, vol. 23, no. 4, pp. 402–408, 1991. View at Google Scholar
  8. W. R. Hiatt, D. Nawaz, J. G. Regensteiner, and K. F. Hossack, “The evaluation of exercise performance in patients with peripheral vascular disease,” Journal of Cardiopulmonary Rehabilitation and Prevention, vol. 12, pp. 525–532, 1988. View at Google Scholar
  9. M. M. McDermott, P. Greenland, K. Liu et al., “Leg symptoms in peripheral arterial disease associated clinical characteristics and functional impairment,” Journal of the American Medical Association, vol. 286, no. 13, pp. 1599–1606, 2001. View at Google Scholar · View at Scopus
  10. M. M. McDermott, K. Liu, P. Greenland et al., “Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms,” Journal of the American Medical Association, vol. 292, no. 4, pp. 453–461, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. M. M. McDermott, K. Liu, E. O'Brien et al., “Measuring physical activity in peripheral arterial disease: a comparison of two physical activity questionnaires with an accelerometer,” Angiology, vol. 51, no. 2, pp. 91–100, 2000. View at Google Scholar · View at Scopus
  12. D. J. Sieminski and A. W. Gardner, “The relationship between free-living daily physical activity and the severity of peripheral arterial occlusive disease,” Vascular Medicine, vol. 2, no. 4, pp. 286–291, 1997. View at Google Scholar
  13. J. E. Ware Jr., “The status of health assessment 1994,” Annual Review of Public Health, vol. 16, pp. 327–354, 1995. View at Google Scholar · View at Scopus
  14. M. M. McDermott, J. M. Guralnik, L. Tian et al., “Baseline functional performance predicts the rate of mobility loss in persons with peripheral arterial disease,” Journal of the American College of Cardiology, vol. 50, no. 10, pp. 974–982, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. L. P. Fried and J. M. Guralnik, “Disability in older adults:evidence regarding significance, etiology, and risk,” Journal of the American Geriatrics Society, vol. 45, no. 1, pp. 92–100, 1997. View at Google Scholar · View at Scopus
  16. A. Afaq, P. S. Montgomery, K. J. Scott, S. M. Blevins, T. L. Whitsett, and A. W. Gardner, “The effect of hypercholestrolemia on calf muscle hemoglobin oxygen saturation in patients with intermittent claudication,” Angiology, vol. 59, no. 5, pp. 534–541, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. A. W. Gardner and P. S. Montgomery, “The effect of metabolic syndrome components on exercise performance in patients with intermittent claudication,” Journal of Vascular Surgery, vol. 47, no. 6, pp. 1251–1258, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. P. S. Yusuf, S. Hawken, S. Ôunpuu et al., “Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study,” The Lancet, vol. 364, no. 9438, pp. 937–952, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Simonsson, C. Schmidt, V. Sigurdadottir, M.-L. Helenius, and B. Fagerberg, “Life style habits such as alcohol consumption and physical activity in relation to serum apoB/apoA-I ratio amongst 64-year-old women with varying degrees of glucose tolerance,” Journal of Internal Medicine, vol. 262, no. 5, pp. 537–544, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. I. Holme, A. T. Høstmark, and S. A. Anderssen, “ApoB but not LDL-cholesterol is reduced by exercise training in overweight healthy men. Results from the 1-year randomized Oslo Diet and Exercise Study,” Journal of Internal Medicine, vol. 262, no. 2, pp. 235–243, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. A. W. Gardner, D. E. Parker, P. S. Montgomery, K. J. Scott, and S. M. Blevins, “Efficacy of quantified home-based exercise and supervised exercise in patients with intermittent claudication: a randomized controlled trial,” Circulation, vol. 123, no. 5, pp. 491–498, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. A. W. Gardner, P. S. Montgomery, K. J. Scott, A. Afaq, and S. M. Blevins, “Patterns of ambulatory activity in subjects with and without intermittent claudication,” Journal of Vascular Surgery, vol. 46, no. 6, pp. 1208–1214, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Alaupovic, “Significance of apolipoproteins for structure, function, and classification of plasma lipoproteins,” Methods in Enzymology, vol. 263, pp. 32–60, 1996. View at Google Scholar · View at Scopus
  24. P. Alaupovic, “The concept of apolipoprotein-defined lipoprotein families and its clinical significance,” Current Atherosclerosis Reports, vol. 5, no. 6, pp. 459–467, 2003. View at Google Scholar · View at Scopus
  25. W. J. McConathy, R. M. Greenhalgh, and P. Alaupovic, “Plasma lipid and apolipoprotein profiles of women with two types of peripheral arterial disease,” Atherosclerosis, vol. 50, no. 3, pp. 295–306, 1984. View at Google Scholar · View at Scopus
  26. W. J. McConathy, P. Alaupovic, N. Woolcock, S. P. Laing, J. Powell, and R. Greenhalgh, “Lipids and apolipoprotein profiles in men with aneurysmal and stenosing aorto-iliac atherosclerosis,” European Journal of Vascular Surgery, vol. 3, no. 6, pp. 511–514, 1989. View at Google Scholar · View at Scopus
  27. M. M. McDermott, J. M. Guralnik, P. Greenland et al., “Statin use and leg functioning in patients with and without lower-extremity peripheral arterial disease,” Circulation, vol. 107, no. 5, pp. 757–761, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. M. H. Criqui, J. O. Denenberg, C. E. Bird, A. Fronek, M. R. Klauber, and R. D. Langer, “The correlation between symptoms and non-invasive test results in patient referred for peripheral arterial disease testing,” Vascular Medicine, vol. 1, no. 1, pp. 65–71, 1996. View at Google Scholar · View at Scopus
  29. G. R. Warnick, J. Benderson, and J. J. Albers, “Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol,” Clinical Chemistry, vol. 28, no. 6, pp. 1379–1388, 1982. View at Google Scholar · View at Scopus
  30. W. T. Friedewald, R. I. Levy, and D. S. Fredrickson, “Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge,” Clinical Chemistry, vol. 18, no. 6, pp. 499–502, 1972. View at Google Scholar · View at Scopus
  31. G. R. Warnick and J. J. Albers, “A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol,” Journal of Lipid Research, vol. 19, no. 1, pp. 65–76, 1978. View at Google Scholar
  32. C.-S. Wang, P. Alaupovic, R. E. Gregg, and H. B. Brewer Jr., “Studies on the mechanism of hypertriglyceridemia in Tangier disease. Determination of plasma lipolytic activities, k1 values and apolipoprotein composition of the major lipoprotein density classes,” Biochimica et Biophysica Acta, vol. 920, no. 1, pp. 9–19, 1987. View at Google Scholar · View at Scopus
  33. P. Riepponen, J. Marniemi, and T. Rautaoja, “Immunoturbidimetric determination of apolipoproteins A-1 and B in serum,” Scandinavian Journal of Clinical and Laboratory Investigation, vol. 47, no. 7, pp. 739–744, 1987. View at Google Scholar · View at Scopus
  34. W. Marz, M. Trommlitz, and W. Gross, “Differential turbidimetric assay for subpopulations of lipoproteins containing apolipoprotein A-I,” Zeitschrift fur klinische Chemie und klinische Biochemie, vol. 26, no. 9, pp. 573–578, 1988. View at Google Scholar · View at Scopus
  35. P. Alaupovic, “Apolipoprotein composition as the basis for classifying plasma lipoproteins: characterization of ApoA- and ApoB-containing lipoprotein families,” Progress in Lipid Research, vol. 30, no. 2-3, pp. 105–138, 1991. View at Publisher · View at Google Scholar · View at Scopus
  36. M. D. Curry, W. J. McConathy, J. D. Fesmire, and P. Alaupovic, “Quantitative determination of human apolipoprotein C-III by electroimmunoassay,” Biochimica et Biophysica Acta, vol. 617, no. 3, pp. 503–513, 1980. View at Google Scholar · View at Scopus
  37. N. Gervaise, M. A. Garrigue, G. Lasfargues, and P. Lecomte, “Triglycerides, apo C3 and Lp B:C3 and cardiovascular risk in Type II diabetes,” Diabetologia, vol. 43, no. 6, pp. 703–708, 2000. View at Google Scholar · View at Scopus
  38. P. Alaupovic, C.-S. Wang, and W. J. McConathy, “Lipolytic degradation of human very low density lipoproteins by human milk lipoprotein lipase: the identification of lipoprotein B as the main lipoprotein degradation product,” Archives of Biochemistry and Biophysics, vol. 244, no. 1, pp. 226–237, 1986. View at Google Scholar · View at Scopus
  39. “Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III),” Journal of the American Medical Association, vol. 285, no. 19, pp. 2486–2497, 2001. View at Scopus
  40. A. W. Gardner, P. S. Montgomery, and D. E. Parker, “Metabolic syndrome impairs physical function, health-related quality of life, and peripheral circulation in patients with intermittent claudication,” Journal of Vascular Surgery, vol. 43, no. 6, pp. 1191–1196, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. C. Behre, G. Bergström, and C. Schmidt, “Moderate physical activity is associated with lower ApoB/ApoA-I ratios independently of other risk factors in healthy, middle-aged men,” Angiology, vol. 61, no. 8, pp. 775–779, 2010. View at Google Scholar · View at Scopus
  42. M. Schillinger, M. Exner, W. Mlekusch et al., “Statin therapy improves cardiovascular outcome of patients with peripheral artery disease,” European Heart Journal, vol. 25, no. 9, pp. 742–748, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. E. R. Mohler III, W. R. Hiatt, and M. A. Creager, “Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease,” Circulation, vol. 108, no. 12, pp. 1481–1486, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. P. Alaupovic, T. Heinonen, L. Shurzinske, and D. M. Black, “Effect of a new HMG-CoA reductase inhibitor, atorvastatin, on lipids, apolipoproteins and lipoprotein particles in patients with elevated serum cholesterol and triglyceride levels,” Atherosclerosis, vol. 133, no. 1, pp. 123–133, 1997. View at Publisher · View at Google Scholar · View at Scopus
  45. R. Nael, P. S. Montgomery, K. J. Scott, S. M. Blevins, and A. W. Gardner, “Gender differences in the prevalence and management of metabolic syndrome and its components in patients with peripheral artery disease,” Angiology, vol. 62, no. 8, pp. 657–661, 2011. View at Publisher · View at Google Scholar · View at Scopus